Cambridge Healthtech Institute’s 11th Annual

Oligonucleotide Discovery & Delivery

Driving Innovation in Design, Development, and Performance for the Next Wave of Oligonucleotide Therapeutics

March 18-19, 2026


Cambridge Healthtech Institute’s Oligonucleotide Discovery & Delivery conference brings together leading voices from biotech, pharma, and academia to showcase breakthroughs across the discovery-to-development continuum. From novel chemistries and RNA modalities, to emerging delivery platforms and clinical translation, this event provides deep insights into the strategies reshaping oligonucleotide therapeutics. Key sessions will explore case studies across RNA, antisense, GalNAc, conjugates, editing therapies, and more—highlighting innovations that are advancing therapeutic precision, extrahepatic delivery, and patient impact.

 

Coverage will include, but is not limited to:

 

  • Translational strategies and success stories from target ID to candidate nomination
  • Next-gen editing tools, including RNA editing, base/prime editing, and gene editing technology e.g., CRISPR
  • Integration of AI/ML in oligonucleotide design, screening, and optimization
  • Progress from early discovery to late-stage clinical development
  • Preclinical and clinical case studies across CNS, liver, oncology, ocular, and rare diseases
  • Breakthroughs in delivery science: GalNAc, lipid systems, conjugates, and beyond
  • Innovations in extrahepatic delivery and tissue targeting
  • Strategic collaboration models between pharma, biotech, and academia
  • Industry perspectives on platform development and pipeline evolution
  • Safety and toxicity considerations for nucleic acids

 

The deadline for priority consideration is September 5, 2025.


Submit a Proposal »

All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute’s policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

 

Opportunities for Participation:

 


For more details on the conference, please contact:

Gemma Smith

Senior Conference Director

Cambridge Healthtech Institute

Phone: (+44) 7866-506-196

Email: gsmith@cambridgeinnovationinstitute.com

 

For sponsorship information, please contact:

Kristin Skahan

Business Development Manager

Cambridge Healthtech Institute

Phone: 781-972-5431

Email: kskahan@healthtech.com


Register Early and Save

Oligonucleotide Discovery & Delivery